Stay updated on Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial page.

Latest updates to the Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial page
- Check3 days agoChange DetectedThe page now displays Revision: v3.5.2, replacing the previous Revision: v3.5.0.SummaryDifference0.0%

- Check10 days agoChange DetectedPadova, Italy (35128) is now listed as a study location, replacing Padua, Italy (35128).SummaryDifference0.0%

- Check17 days agoChange DetectedAdded the related topic Squamous cell carcinoma of the head and neck and included the Genetic and Rare Diseases Information Center as a resource.SummaryDifference0.1%

- Check24 days agoChange DetectedNaples, Italy, 80121 was added and Napoli, Italy, 80121 was removed, and the revision tag changed from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page revision was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check67 days agoChange DetectedPlain Language Summary has been added to the Study Details page to improve readability of the trial information. The record now shows a new revision (v3.4.2) and recent update dates (2025-12, 2026-01, 2026-02-04), replacing the previous v3.4.0.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial page.